Gynesonics
OverviewSuggest Edit
Gynesonics is a company that develops an ablation device for treating uterine fibroids. Its Sonata (Sonography-Guided Transcervical Fibroid Ablation) system is intended for the diagnostic intrauterine imaging and transcervical treatment of symptomatic uterine fibroids, including those associated with heavy menstrual bleeding.
| Type | Private | |
| Founded | 2005 | |
| HQ | Redwood City, CA, US | Map |
| Website | gynesonics.com |
Recent NewsAll News
- Gynesonics Announces First Office-Based Sonata Procedure in the State of Texas
- Gynesonics Names Robert Brown Chief Financial Officer
- Gynesonics Announces FDA Clearance of Next Generation Sonata System
- Gynesonics Announces Anthem, the Second Largest Healthcare Payer in the U.S., Issues Medical Necessity Coverage for the Treatment of Symptomatic Uterine Fibroids with the Sonata Procedure
Latest Updates
| Employees (est.) (Oct 2021) | 101 | (+3%) |
| Cybersecurity rating | A | More |
Key People/Management at Gynesonics
Chris Owens
President, CEO & Director
Jordan Bajor
Chief Operating Officer
Susan Stimson
Director
Jiayu Chen
Vice President, Engineering and Advanced Technologies
Taraneh G. Farazi
Senior Vice President, Global Clinical Strategy and Scientific Innovation
Diane King
Vice President, Regulatory Affairs and Quality Assurance
Gynesonics Office Locations
Gynesonics has offices in Redwood City and Beuningen
Redwood City, CA, US (HQ)
600 Chesapeake Dr
Beuningen, NL
De Haaghe 2
Gynesonics Financials and Metrics
Summary Metrics
Founding Date | 2005 |
Gynesonics total Funding | $153.4 m |
Gynesonics latest funding size | $75 m |
Time since last funding | 3 years ago |
Gynesonics investors | Advanced Technology Ventures, InterWest Partners, Correlation Ventures, Endeavour Vision, Abingworth, HBM Partners, Hercules Capital, Bain Capital Life Sciences, HealthCrest |
Gynesonics's latest funding round in January 2019 was reported to be $75 m. In total, Gynesonics has raised $153.4 m
Gynesonics Operating Metrics
Show all operating metricsGynesonics Cybersecurity Score
Gynesonics Online and Social Media Presence
Gynesonics's Trends
Gynesonics Blogs
October 05, 2021
Gynesonics Announces First Office-Based Sonata Procedure in the State of Texas
Dr. John Thoppil, Current President of the Texas Association of Obstetricians and Gynecologists (TAOG), Performs Sonata Procedure in Austin Redwood City, CA, October 5, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine…
September 29, 2021
Gynesonics Names Robert Brown Chief Financial Officer
Redwood City, CA, September 29, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that Robert Brown has joined the company as Chief Financial Officer, starting immediately. Mr. Brown’s backgro…
September 16, 2021
Gynesonics Announces FDA Clearance of Next Generation Sonata System
The Only Transcervical, Incisionless System for Radiofrequency Ablation of Fibroids Provides New Benefits through Features Such as Increased Range of Ablation Sizes, a New User Interface, and Validation of Additional Low Temperature Hospital Reprocessing Systems Redwood City, CA, September 16, 2021 …
September 14, 2021
Gynesonics Announces Anthem, the Second Largest Healthcare Payer in the U.S., Issues Medical Necessity Coverage for the Treatment of Symptomatic Uterine Fibroids with the Sonata Procedure
Anthem’s decision significantly increases nationwide access for Sonata Redwood City, CA, September 14, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced Anthem, Inc., the largest managed health car…
August 11, 2021
Gynesonics Announces Expert Group of European Gynecologic Surgeons Publishes Consensus on the Broad Use of the Sonata Technology in a New Treatment Strategy for Symptomatic Fibroids
The Combined Clinical Experience of Over 1000 Sonata Procedures, Across Three Countries, Drives New Recommendation for Sonata as a First Line Therapy for Fibroid Treatment Redwood City, CA, August 11, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive s…
June 10, 2021
Gynesonics Announces Positive Payer Coverage Issued by Blue Cross Blue Shield of Florida (Florida Blue) for the Sonata Treatment
Florida Blue is the Largest Healthcare Payer in that State Redwood City, CA, June 11, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today Blue Cross Blue Shield of Florida (Florida Blue) has re…
Gynesonics Frequently Asked Questions
When was Gynesonics founded?
Gynesonics was founded in 2005.
Who are Gynesonics key executives?
Gynesonics's key executives are Chris Owens, Jordan Bajor and Susan Stimson.
How many employees does Gynesonics have?
Gynesonics has 101 employees.
Who are Gynesonics competitors?
Competitors of Gynesonics include Infogene, Layla Wellness and AblaCare.
Where is Gynesonics headquarters?
Gynesonics headquarters is located at 600 Chesapeake Dr, Redwood City.
Where are Gynesonics offices?
Gynesonics has offices in Redwood City and Beuningen.
How many offices does Gynesonics have?
Gynesonics has 2 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies